Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs Propofol for Postoperative Delirium in Elderly Laparoscopic Colon Cancer Surgery
ChiCTR2600125477Phase 4Recruiting
- Sponsor
- Affiliated Suzhou Hospital of Nanjing Medical University
- Start
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam in colon cancer and postoperative delirium (POD) (2 arms), sponsored by Affiliated Suzhou Hospital of Nanjing Medical University. Primary endpoint: Incidence of postoperative delirium. Started May 2026; status: recruiting.
02
Drugs
remimazolam
03
Conditions
colon cancerpostoperative delirium (POD)
Beyond the preview
Go deeper on ChiCTR2600125477.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600125477.